NSEDCP
NJ State Employees Deferred Compensation Plan’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $512K | Hold |
15,500
| – | – | 0.06% | 277 |
|
|
2025
Q1 | $623K | Hold |
15,500
| – | – | 0.08% | 232 |
|
|
2024
Q4 | $729K | Hold |
15,500
| – | – | 0.09% | 220 |
|
|
2024
Q3 | $818K | Hold |
15,500
| – | – | 0.1% | 205 |
|
|
2024
Q2 | $840K | Hold |
15,500
| – | – | 0.1% | 190 |
|
|
2024
Q1 | $1.09M | Hold |
15,500
| – | – | 0.14% | 163 |
|
|
2023
Q4 | $1.29M | Hold |
15,500
| – | – | 0.18% | 124 |
|
|
2023
Q3 | $457K | Hold |
15,500
| – | – | 0.07% | 277 |
|
|
2023
Q2 | $506K | Hold |
15,500
| – | – | 0.07% | 271 |
|
|
2023
Q1 | $545K | Buy |
15,500
+8,000
| +107% | +$282K | 0.08% | 253 |
|
|
2022
Q4 | $344K | Hold |
7,500
| – | – | 0.06% | 342 |
|
|
2022
Q3 | $363K | Buy |
+7,500
| New | +$363K | 0.06% | 320 |
|